In the BioHarmony Drug Report Database

"Preview" Icon

Clofarabine

Clolar, Evoltra (clofarabine) is a small molecule pharmaceutical. Clofarabine was first approved as Clolar on 2004-12-28. It is used to treat lymphoid leukemia in the USA. It has been approved in Europe to treat precursor cell lymphoblastic leukemia-lymphoma. The pharmaceutical is active against ribonucleoside-diphosphate reductase subunit M2. In addition, it is known to target ribonucleoside-diphosphate reductase large subunit and deoxycytidine kinase.

 

Trade Name

 

Evoltra
 

Common Name

 

clofarabine
 

ChEMBL ID

 

CHEMBL1750
 

Indication

 

lymphoid leukemia, precursor cell lymphoblastic leukemia-lymphoma
 

Drug Class

 

Antineoplastics (arabinofuranosyl derivatives)

Image (chem structure or protein)

Clofarabine structure rendering